CRSP CRISPR Therapeutics AG
2026Q1 · CUSIP H17182108 · Sector: Healthcare & Biotech
Cooling · Breadth rolling over
Holders
489
Δ holders QoQ
+7
Breadth percentile
Top 37%
Whale holders
155
Δ whales
+1
Inst. holding value
$3.6B
New positions
81
Closed positions
74
Price momentum (1Q)
—
Put / Call
12/22
Breadth history (34 quarters)
Past Lit Events & Aftermath 14 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 12% | — | — |
| 2025Q2 | Top 6% | — | — |
| 2023Q4 | Top 6% | — | — |
| 2023Q2 | Top 5% | — | — |
| 2021Q2 | Top 2% | — | — |
| 2021Q1 | Top 10% | — | — |
| 2020Q4 | Top 4% | — | — |
| 2020Q3 | Top 6% | — | — |
Options Sentiment
Put holders
12
QoQ: -2
Call holders
22
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-6.17
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-89.1%
Net margin
—
ROE
-31.3%
Debt ratio
33.4%
FCF (TTM)
-$401M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.